Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco - Presidio Ospedaliero G. Rodolico

Catania 95124

2 studies enrolling now · 5 studies all time

What they study most

B Cell Precursor Acute Lymphoblastic Leukemia, HER2 Exon 20 Mutation, Indolent Systemic Mastocytosis, Myelofibrosis, Non-Small Cell Lung Cancer (NSCLC), Non-squamous NSCLC, Phosphomannomutase 2 Deficiency, Pmm2-CDG

Studies at this site

• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) — Recruiting now
• Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients — Enrolling by invitation
• A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL — Running, not enrolling
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis — Status unconfirmed